You are here

Nurix Therapeutics

Sanofi taps Nurix for pipeline nourishment once again, picking up autoimmune degrader for $15M

Fierce Biotech

Wed, 04/2/25 - 11:40 am

Nurix Therapeutics

autoimmune diseases

protein degradation

Nurix Therapeutics’ NX-5948 shows promise in Waldenstrom’s macroglobulinaemia trial

Clinical Trials Arena

Mon, 10/21/24 - 11:32 am

Nurix Therapeutics

clinical trials

Waldenström’s macroglobulinemia

Gilead dives deeper into Nurix protein degrader collab, paying $15M for 2-year extension

Fierce Biotech

Tue, 04/2/24 - 11:38 am

Gilead Sciences

Nurix Therapeutics

protein degradation

Nurix and Seagen Collaborate on Breakthrough Cancer Therapeutics

Globe Newswire

Thu, 09/7/23 - 10:57 am

Nurix Therapeutics

protein degradation

antibody-drug conjugate

ASH 2022 – pirtobrutinib leads the post-Imbruvica charge

EP Vantage

Wed, 12/14/22 - 10:18 am

Nurix Therapeutics

Biopharma Companies Entering 2021 With New Collabs, Partnerships

BioSpace

Sat, 01/9/21 - 07:42 pm

Dewpoint Therapeutics

Nurix Therapeutics

This week's wave of biotech IPO players bumps up offerings and targets bigger harvests of cash

Endpoints

Thu, 07/23/20 - 11:16 am

Nurix Therapeutics